463 results
·
21ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 3
×
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·Restylane Injectable Gel
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·RESTYLANE, RESTYLANE-L, PERLANE, RESTYLANE LYFT, RESTYLANE SILK
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·RESTYLANE INJECTABLE GEL
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·RESTYLANE INJECTABLE GEL
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·RESTYLANE, RESTYLANE-L, RESTYLANE LYFT, RESTYLANE SILK, PERLANE
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·RESTYLANE INJECTABLE GEL
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·Restylane Refyne, Restylane Defyne Injectable Gels
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·RESTYLANE
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·SCULPTRA
Replacer, Ureteral
FDA classification
FDA Class 3
·Replacer, Ureteral
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·VENTANA PD-L1(SP142) CDX ASSAY
Light Adjustable Lens (Lal) And Light Delivery Device (Ldd)
FDA classification
FDA Class 3
·Light Adjustable Lens (Lal) And Light Delivery Device (Ldd)
Immunohistochemistry Assay, Antibody, Met
FDA Pre-Market Approval
FDA Class 3
·VENTANA MET (SP44) RxDx Assay
Immunohistochemistry Assay, Antibody, Claudin 18
FDA Pre-Market Approval
FDA Class 3
·VENTANA CLDN18 (43-14A) RxDx Assay
Immunohistochemistry Assay, Antibody, Folr1
FDA Pre-Market Approval
FDA Class 3
·VENTANA FOLR1 (FOLR-2.1) RxDx Assay
System, Test, Her-2/Neu, Ihc
FDA Pre-Market Approval
FDA Class 3
·PATHWAY anti-HER-2/neu (4B5) Rabbit Monoclonal Primary Antibody
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·VENTANA PD-L1 (SP142) Assay
Immunohistochemistry Antibody Assay, C-Kit
FDA Pre-Market Approval
FDA Class 3
·VENTANA MEDICAL SYSTEMS PATHWAY ANTI-C-KIT (9.7) PRIMARY ANTIBODY
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·VENTANA PD-L1 (SP263) ASSAY
System, Test, Her-2/Neu, Ihc
FDA Pre-Market Approval
FDA Class 3
·PATHWAY anti-HER-2/neu (4B5) Rabbit Monoclonal Primary Antibody